Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
cancer
deals
gene therapy
sarepta therapeutics
startups
abbvie
astrazeneca
avexis
biogen
biomarin pharmaceutical
bristol-myers squibb
What
bio
fda
5
×
roundup
5
×
drugs
news
drug
activity
ahead
approvals
approved
aren’t
asco
august
biogen
biotech
branded
busy
choices
clamped
commissioner
companies
consumers
costly
counterweight
covid
days
decisions
delays
developers
developing
devices
digital
disease
economic
elevatebio
epidemic
fast
fatty
frenzied
gene
Language
unset
Current search:
roundup
×
fda
×
@xconomy.com
3 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
